Hypermethylation of TMEM240 predicts poor hormone therapy response and disease progression in breast cancer.
- Published in:
- Molecular Medicine, 2022, v. 28, n. 1, p. 1, doi. 10.1186/s10020-022-00474-9
- By:
- Publication type:
- Article
Works by Liew, Phui-Ly
Results: 16
1
2
GATA3 as a master regulator and therapeutic target in ovarian high‐grade serous carcinoma stem cells.
- Published in:
- International Journal of Cancer, 2018, v. 143, n. 12, p. 3106, doi. 10.1002/ijc.31750
- By:
- Publication type:
- Article
3
Epigenetic loss of heparan sulfate 3‐O‐sulfation sensitizes ovarian carcinoma to oncogenic signals and predicts prognosis.
- Published in:
- International Journal of Cancer, 2018, v. 143, n. 8, p. 1943, doi. 10.1002/ijc.31580
- By:
- Publication type:
- Article
4
Distinct methylation profile of mucinous ovarian carcinoma reveals susceptibility to proteasome inhibitors.
- Published in:
- International Journal of Cancer, 2018, v. 143, n. 2, p. 355, doi. 10.1002/ijc.31324
- By:
- Publication type:
- Article
5
Correction: In vitro drug testing using patient-derived ovarian cancer organoids.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
6
In vitro drug testing using patient-derived ovarian cancer organoids.
- Published in:
- Journal of Ovarian Research, 2024, v. 17, n. 1, p. 1, doi. 10.1186/s13048-024-01520-2
- By:
- Publication type:
- Article
7
Complete remission of heavily treated ovarian clear cell carcinoma with ARID1A mutations after pembrolizumab and bevacizumab combination therapy: a case report.
- Published in:
- Journal of Ovarian Research, 2020, v. 13, n. 1, p. 1, doi. 10.1186/s13048-020-00751-3
- By:
- Publication type:
- Article
8
Actinomycosis of the Salivary Gland
- Published in:
- Tzu Chi Medical Journal, 2008, v. 20, n. 3, p. 218, doi. 10.1016/S1016-3190(08)60039-7
- By:
- Publication type:
- Article
9
BHLHE22 Expression Is Associated with a Proinflammatory Immune Microenvironment and Confers a Favorable Prognosis in Endometrial Cancer.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 13, p. 7158, doi. 10.3390/ijms23137158
- By:
- Publication type:
- Article
10
Epigenomic Analysis Reveals the KCNK9 Potassium Channel as a Potential Therapeutic Target for Adenomyosis.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 11, p. 5973, doi. 10.3390/ijms23115973
- By:
- Publication type:
- Article
11
Erratum to: Survivin-mediated Therapeutic Efficacy of Gemcitabine through Glucose-regulated Protein 78 in Hepatocellular Carcinoma.
- Published in:
- 2014
- By:
- Publication type:
- Erratum
12
Survivin-mediated Therapeutic Efficacy of Gemcitabine through Glucose-regulated Protein 78 in Hepatocellular Carcinoma.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2012, v. 19, n. 8, p. 2744, doi. 10.1245/s10434-011-2188-z
- By:
- Publication type:
- Article
13
Nerve growth factor interacts with CHRM4 and promotes neuroendocrine differentiation of prostate cancer and castration resistance.
- Published in:
- Communications Biology, 2021, v. 4, n. 1, p. 1, doi. 10.1038/s42003-020-01549-1
- By:
- Publication type:
- Article
14
Active DNA Demethylase, TET1, Increases Oxidative Phosphorylation and Sensitizes Ovarian Cancer Stem Cells to Mitochondrial Complex I Inhibitor.
- Published in:
- Antioxidants, 2024, v. 13, n. 6, p. 735, doi. 10.3390/antiox13060735
- By:
- Publication type:
- Article
15
Hypermethylation and decreased expression of TMEM240 are potential early-onset biomarkers for colorectal cancer detection, poor prognosis, and early recurrence prediction.
- Published in:
- Clinical Epigenetics, 2020, v. 12, n. 1, p. 1, doi. 10.1186/s13148-020-00855-z
- By:
- Publication type:
- Article
16
Combined genetic mutations and DNA-methylated genes as biomarkers for endometrial cancer detection from cervical scrapings.
- Published in:
- Clinical Epigenetics, 2019, v. 11, n. 1, p. N.PAG, doi. 10.1186/s13148-019-0765-3
- By:
- Publication type:
- Article